Ads
related to: betmiga overactive bladder treatmentelitone.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. [5] Its benefits are similar to antimuscarinic medication such as solifenacin or tolterodine. [6] It is taken by mouth. [5] Common side effects include high blood pressure, headaches, and urinary tract infections. [5]
Vibegron, sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder. [1] [5] [6] Vibegron is a selective beta-3 adrenergic receptor agonist. [1] The most common side effects include headache, urinary tract infection, common cold, diarrhea, nausea, and upper respiratory tract infection. [5]
More recently pharmaceutical companies have developed selective β 3-AR agonists targeted at urinary inconsistencies and in 2012 Mirabegron (trade name Myrbetriq and Betmiga) was the first β 3-AR agonist to be approved in the United States and Europe for the treatment of overactive bladder (OAB) syndrome. [1] [2]
Overactive bladder isn’t a disease but rather a syndrome defined by a collection of symptoms, says Jennifer Linehan, MD, a urologist and associate professor of urologic oncology at the John ...
“Once the cause is identified, the doctor will suggest an appropriate treatment,” Dr. Nocerino says. This may include medications, swallowing therapy, surgery or endoscopic treatments.
In Malawi, clinics could soon be running out of critical HIV medication, unable to replenish their supply since the Trump administration ordered a freeze to U.S. foreign aid. The pause has halted ...
Ads
related to: betmiga overactive bladder treatmentelitone.com has been visited by 10K+ users in the past month